Xiaodi Zhao

16PUBLICATIONS
31CO-AUTHORS
Innate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 28, 2026
Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities.

|Jan 31, 2026
SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic-transcriptional reprogramming.

Yelu Zhou, Yanxing Liu, Yi Liu

|Jan 30, 2026
Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapy.

Sifan Li, Chang Che, Yelu Zhou

|Sep 24, 2025
Extracellular Vesicle-Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche That Drives Colorectal Cancer Metastasis.

Mingzhen Zhou, Hao Liu, Juan Hui

|Apr 05, 2025
Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer.

Shuyi Chen, Tingyu Li, Dan Liu

|Aug 23, 2024
The current role of dendritic cells in the progression and treatment of colorectal cancer.

Yuanci Zhang, Songtao Ji, Ge Miao

Pageof 3

Frequent Collaborators

4 joint publications

Yuanyuan Lu

3 joint publications

Xin Wang

2 joint publications

Stephan Emmrich

2 joint publications

Hua Han